CIBC Private Wealth Group’s VanEck Biotech ETF BBH Stock Holding History

CIBC Private Wealth Group’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$938K	Hold	4,958	–	–	﹤0.01%	716
2025 Q3	$821K	Hold	4,958	–	–	﹤0.01%	741
2025 Q2	$760K	Hold	4,958	–	–	﹤0.01%	720
2025 Q1	$695K	Hold	4,958	–	–	﹤0.01%	731
2024 Q4	$796K	Hold	4,958	–	–	﹤0.01%	748
2024 Q3	$880K	Hold	4,958	–	–	﹤0.01%	717
2024 Q2	$839K	Hold	4,958	–	–	﹤0.01%	698
2024 Q1	$823K	Buy	4,958 +1,500	+43%	+$248K	﹤0.01%	712
2023 Q4	$572K	Buy	+3,458	New	+$532K	﹤0.01%	766
2022 Q1	–	Sell	-6,473	Closed	-$1.23M	–	1266
2021 Q4	$1.23M	Buy	+6,473	New	+$1.25M	﹤0.01%	613
2018 Q3	–	Sell	-80	Closed	-$10K	–	1037
2018 Q2	$10K	Hold	80	–	–	﹤0.01%	1555
2018 Q1	$10K	Hold	80	–	–	﹤0.01%	1525
2017 Q4	$10K	Buy	+80	New	+$10.2K	﹤0.01%	1542

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

CIBC Private Wealth Group's BBH Position: Q4 2025 in Review

CIBC Private Wealth Group held its VanEck Biotech ETF (BBH) position steady in Q4 2025 at 4,958 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

CIBC Private Wealth Group first reported a position in BBH in Q4 2017 and has held it in 13 quarters since. The position peaked at $1.23M in Q4 2021. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

CIBC Private Wealth Group held 4,958 shares of VanEck Biotech ETF worth $938K as of Q4 2025.
CIBC Private Wealth Group left its VanEck Biotech ETF share count unchanged in Q4 2025.
VanEck Biotech ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #716 holding.
CIBC Private Wealth Group first reported a position in VanEck Biotech ETF in Q4 2017 and has held it in 13 quarters since.
CIBC Private Wealth Group's VanEck Biotech ETF position peaked at $1.23M in Q4 2021.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.